Biosimilars are essential for sustainable healthcare systems; however, key challenges remain as seen with long-acting insulin analogues

Journal of Applied Pharmaceutical Science(2022)

Cited 1|Views15
No score
Abstract
Generic competition and drug prices in the Malaysian off-patent pharmaceutical marketOmotayo Fatokun, Mohamed Izham Mohamed Ibrahim, Mohamed Azmi Hassali
More
Translated text
Key words
biosimilars,insulin,sustainable healthcare systems,long-acting
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined